First Time Loading...

Australian Pharmaceutical Industries Ltd
ASX:API

Watchlist Manager
Australian Pharmaceutical Industries Ltd Logo
Australian Pharmaceutical Industries Ltd
ASX:API
Watchlist
Price: 1.53 AUD Market Closed
Updated: May 7, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

4B
+0.9%
Revenue
Growth Rates:
1 Year
-34%
3 Years
-1%
5 Years
+4%
7 Years
+20%
10 Years
+17%
23.9m
-20%
Operating Income
Growth Rates:
1 Year
-63%
3 Years
-71%
5 Years
-72%
7 Years
+273%
10 Years
-
1.4m
Net Income
Growth Rates:
1 Year
-90%
3 Years
-97%
5 Years
-97%
7 Years
-
10 Years
-

Earnings Waterfall
Australian Pharmaceutical Industries Ltd

Revenue
4B AUD
Cost of Revenue
-3.5B AUD
Gross Profit
496.6m AUD
Operating Expenses
-472.7m AUD
Operating Income
23.9m AUD
Other Expenses
-22.5m AUD
Net Income
1.4m AUD

Income Statement
Australian Pharmaceutical Industries Ltd

Rotate your device to view
Income Statement
Currency: AUD
Apr-2003 Oct-2003 Apr-2004 Oct-2004 Apr-2005 Oct-2005 Apr-2006 Oct-2006 Apr-2007 Feb-2008 Aug-2008 Feb-2009 Aug-2009 Feb-2010 Aug-2010 Feb-2011 Aug-2011 Feb-2012 Aug-2012 Feb-2013 Aug-2013 Feb-2014 Aug-2014 Feb-2015 Aug-2015 Feb-2016 Aug-2016 Feb-2017 Aug-2017 Feb-2018 Aug-2018 Feb-2019 Aug-2019 Feb-2020 Feb-2020 Aug-2020 Feb-2021 Aug-2021
Revenue
Revenue
2 485
N/A
2 828
+14%
2 944
+4%
2 812
-4%
2 323
-17%
2 273
-2%
2 582
+14%
2 582
0%
2 649
+3%
2 970
+12%
3 239
+9%
3 365
+4%
3 550
+5%
3 665
+3%
3 706
+1%
3 705
0%
3 426
-8%
3 186
-7%
3 199
+0%
3 192
0%
3 166
-1%
3 226
+2%
3 346
+4%
3 402
+2%
3 462
+2%
3 539
+2%
3 845
+9%
4 071
+6%
4 067
0%
4 064
0%
4 035
-1%
4 002
-1%
4 016
+0%
6 108
+52%
6 108
N/A
6 061
-1%
3 970
-34%
4 007
+1%
Gross Profit
Cost of Revenue
(2 253)
(2 566)
(2 681)
(2 560)
(2 029)
(1 916)
(2 231)
(2 259)
(2 321)
(2 606)
(2 876)
(3 008)
(3 181)
(3 295)
(3 338)
(3 332)
(3 056)
(2 809)
(2 810)
(2 792)
(2 762)
(2 809)
(2 914)
(2 956)
(3 004)
(3 069)
(3 362)
(3 581)
(3 568)
(3 564)
(3 530)
(3 474)
(3 492)
(5 337)
(5 337)
(5 323)
(3 498)
(3 510)
Gross Profit
232
N/A
262
+13%
263
+0%
250
-5%
295
+18%
357
+21%
351
-2%
323
-8%
328
+2%
364
+11%
363
0%
357
-2%
369
+3%
370
+0%
368
-1%
373
+1%
370
-1%
378
+2%
389
+3%
400
+3%
404
+1%
417
+3%
432
+4%
446
+3%
459
+3%
470
+2%
483
+3%
490
+1%
500
+2%
499
0%
506
+1%
527
+4%
524
-1%
771
+47%
771
N/A
738
-4%
473
-36%
497
+5%
Operating Income
Operating Expenses
(187)
(221)
(231)
(221)
(240)
(302)
(312)
(325)
(321)
(321)
(315)
(309)
(326)
(328)
(323)
(379)
(385)
(346)
(353)
(358)
(365)
(422)
(426)
(379)
(385)
(391)
(396)
(399)
(410)
(417)
(423)
(443)
(452)
(681)
(681)
(673)
(443)
(473)
Selling, General & Administrative
(187)
(221)
(231)
(219)
(245)
(307)
(299)
(312)
(333)
(330)
(325)
(319)
(326)
(328)
(323)
(380)
(385)
(346)
(353)
(358)
(365)
(422)
(425)
(379)
(385)
(391)
(397)
(399)
(410)
(417)
(423)
(443)
(452)
(681)
(681)
(673)
(443)
(473)
Other Operating Expenses
0
0
0
(3)
5
5
(13)
(13)
13
9
11
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Operating Income
45
N/A
42
-7%
33
-22%
31
-6%
55
+78%
55
+1%
39
-29%
(2)
N/A
7
N/A
43
+508%
49
+13%
49
0%
43
-11%
42
-2%
45
+7%
(6)
N/A
(15)
-161%
32
N/A
36
+15%
42
+16%
39
-6%
(5)
N/A
6
N/A
68
+955%
74
+9%
79
+7%
86
+9%
91
+5%
89
-2%
83
-7%
82
0%
84
+2%
72
-14%
91
+26%
91
N/A
65
-28%
30
-54%
24
-20%
Pre-Tax Income
Interest Income Expense
(9)
(7)
(5)
(3)
(9)
(11)
(13)
(19)
(23)
(25)
(28)
(27)
(22)
(16)
(13)
(11)
(6)
(5)
(3)
(2)
(1)
(24)
(29)
(9)
(10)
(13)
(13)
(9)
(8)
(8)
(8)
(9)
6
11
11
(6)
(12)
(11)
Non-Reccuring Items
0
0
0
0
0
0
0
4
0
0
0
0
6
6
4
(7)
(4)
21
15
0
1
(57)
(58)
0
0
1
1
1
0
0
0
0
0
0
0
(37)
(35)
3
Total Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(3)
(5)
(4)
(5)
(5)
(4)
(4)
(5)
(5)
(5)
(5)
(5)
(5)
(5)
(5)
(5)
(5)
(5)
(7)
(7)
(6)
(3)
(3)
Pre-Tax Income
36
N/A
34
-5%
27
-20%
27
0%
45
+66%
44
-2%
26
-40%
(17)
N/A
(16)
+8%
19
N/A
21
+14%
22
+3%
27
+23%
32
+21%
36
+11%
(27)
N/A
(30)
-12%
44
N/A
43
0%
36
-18%
35
-2%
(91)
N/A
(85)
+7%
54
N/A
59
+10%
62
+4%
69
+11%
77
+12%
76
-1%
70
-8%
70
0%
70
+1%
74
+5%
96
+30%
96
N/A
16
-84%
(21)
N/A
12
N/A
Net Income
Tax Provision
(13)
(12)
(9)
(8)
(13)
(13)
(8)
6
4
(7)
(6)
(6)
(9)
(10)
(13)
4
7
(13)
(13)
(11)
(11)
(12)
(6)
(9)
(16)
(17)
(17)
(19)
(24)
(22)
(22)
(22)
(17)
(19)
(19)
(0)
7
(11)
Income from Continuing Operations
24
22
19
20
32
31
19
(12)
(12)
12
15
16
18
22
23
(23)
(23)
30
30
25
24
(104)
(91)
46
43
45
52
58
52
48
48
48
57
77
77
15
(14)
1
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(1)
(1)
(2)
(2)
(1)
0
0
Net Income (Common)
24
N/A
22
-8%
19
-15%
20
+6%
35
+76%
35
+1%
21
-41%
(11)
N/A
(11)
-6%
12
N/A
15
+27%
16
+4%
18
+16%
22
+21%
23
+2%
(23)
N/A
(23)
-1%
30
N/A
30
+1%
25
-18%
24
-2%
(104)
N/A
(91)
+12%
46
N/A
43
-5%
45
+4%
52
+15%
58
+12%
52
-10%
48
-8%
48
0%
47
-1%
55
+16%
74
+35%
74
N/A
14
-81%
(13)
N/A
1
N/A
EPS (Diluted)
0.09
N/A
0.08
-11%
0.07
-13%
0.07
N/A
0.11
+57%
0.11
N/A
0.07
-36%
-0.03
N/A
-0.04
-33%
0.04
N/A
0.05
+25%
0.05
N/A
0.06
+20%
0.06
N/A
0.05
-17%
-0.05
N/A
-0.05
N/A
0.06
N/A
0.06
N/A
0.05
-17%
0.05
N/A
-0.21
N/A
-0.19
+10%
0.09
N/A
0.09
N/A
0.09
N/A
0.1
+11%
0.12
+20%
0.11
-8%
0.1
-9%
0.1
N/A
0.1
N/A
0.11
+10%
0.15
+36%
0.15
N/A
0.03
-80%
-0.03
N/A
0
N/A

See Also

Summary
API intrinsic value, competitors valuation, and company profile.
DCF Valuation
API stock valuation using Discount Cash Flow valuation method.
Relative Valuation
API stock valuation using valuation multiples.
Wall Street Estimates
API price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
API stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.